These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 7271039)

  • 21. Immunogenicity of a Moraxella bovis bacterin containing attachment and cornea-degrading enzyme antigens.
    Gerber JD; Selzer NL; Sharpee RL; Beckenhauer WH
    Vet Immunol Immunopathol; 1988 Feb; 18(1):41-52. PubMed ID: 3376421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infectious bovine keratoconjunctivitis: evidence for general immunity.
    Kopecky KE; Pugh GW; McDonald TJ
    Am J Vet Res; 1983 Feb; 44(2):260-2. PubMed ID: 6830015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infectious bovine keratoconjunctivitis: experimental induction of infection in calves with mycoplasmas and Moraxella bovis.
    Pugh GW; Hughes DE; Schulz VD
    Am J Vet Res; 1976 May; 37(5):493-5. PubMed ID: 1275332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serologic response of vaccinated cattle to strains of Moraxella bovis isolated during epizootics of keratoconjunctivitis.
    Pugh GW; Hughes DE; Booth GD
    Am J Vet Res; 1978 Jan; 39(1):55-7. PubMed ID: 415645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimentally induced infectious bovine keratoconjunctivitis: vaccination with nonviable Moraxella bovis culture.
    Hughes DE; Pugh GW
    Am J Vet Res; 1972 Dec; 33(12):2475-9. PubMed ID: 4641206
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of vaccination and treatment in controlling naturally occurring infectious bovine keratoconjunctivitis.
    Hughes DE; Kohlmeier RH; Pugh GW; Booth GD
    Am J Vet Res; 1979 Feb; 40(2):241-4. PubMed ID: 464360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wavelength of ultraviolet radiation that enhances onset of clinical infectious bovine keratoconjunctivitis.
    Kopecky KE; Pugh GW; Hughes DE
    Am J Vet Res; 1980 Sep; 41(9):1412-5. PubMed ID: 7447134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bovine infectious keratoconjunctivitis: carrier state of Moraxella bovis and the development of preventive measures against disease.
    Pugh GW; Hughes DE
    J Am Vet Med Assoc; 1975 Aug; 167(4):310-3. PubMed ID: 1097382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of Moraxella bovis hemolysin.
    Ostle AG; Rosenbusch RF
    Am J Vet Res; 1985 May; 46(5):1011-4. PubMed ID: 2408520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Hess JF; George LW
    Vaccine; 2004 Dec; 23(4):537-45. PubMed ID: 15530703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination against infectious bovine keratoconjunctivitis: protective efficacy and antibody response induced by pili of homologous and heterologous strains of Moraxella bovis.
    Lepper AW
    Aust Vet J; 1988 Oct; 65(10):310-6. PubMed ID: 2904257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infectious bovine keratoconjunctivitis: evidence for genetic modulation of resistance in purebred Hereford cattle.
    Pugh GW; McDonald TJ; Kopecky KE; Kvasnicka WG
    Am J Vet Res; 1986 Apr; 47(4):885-9. PubMed ID: 3516033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serologic and protective characterization of Moraxella bovis pili.
    Lehr C; Jayappa HG; Goodnow RA
    Cornell Vet; 1985 Oct; 75(4):484-92. PubMed ID: 2865080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serologic cross-reactivity of Australian Moraxella bovis to vaccinal bacterin strains as determined by competitive ELISA.
    McConnel CS; Shum L; Gleeson BL; House JK
    Aust Vet J; 2008 Apr; 86(4):124-9. PubMed ID: 18363984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors related to the prevalence of infectious bovine keratoconjunctivitis.
    Webber JJ; Selby LA
    J Am Vet Med Assoc; 1981 Oct; 179(8):823-6. PubMed ID: 6281222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of infectious bovine keratoconjunctivitis by modified-live infectious bovine rhinotracheitis virus vaccine.
    George LW; Ardans A; Mihalyi J; Guerra MR
    Am J Vet Res; 1988 Nov; 49(11):1800-6. PubMed ID: 2854704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized and blinded field trial to assess the efficacy of an autogenous vaccine to prevent naturally occurring infectious bovine keratoconjunctivis (IBK) in beef calves.
    Funk L; O'Connor AM; Maroney M; Engelken T; Cooper VL; Kinyon J; Plummer P
    Vaccine; 2009 Jul; 27(34):4585-90. PubMed ID: 19531391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK).
    Lepper AW; Atwell JL; Lehrbach PR; Schwartzkoff CL; Egerton JR; Tennent JM
    Vet Microbiol; 1995 Jul; 45(2-3):129-38. PubMed ID: 7571364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental production of infectious bovine keratoconjunctivitis: comparison of serological and immunological responses using pili fractions of Moraxella bovis.
    Pugh GW; Hughes DE
    Can J Comp Med; 1976 Jan; 40(1):60-6. PubMed ID: 1000379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A field trial of autogenous Moraxella bovis bacterin administered through either subcutaneous or subconjunctival injection on the development of keratoconjunctivitis in a beef herd.
    Davidson HJ; Stokka GL
    Can Vet J; 2003 Jul; 44(7):577-80. PubMed ID: 12892288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.